Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 9/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | GRM8 | O00222 | 1/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1870730 | 1.00 | LTA4H (0.54) | LTA4HMEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL14586345 | 1.00 | LTA4H (0.54) | LTA4HMEN1ALDH1A1LMNAKMT2A | |
| Ammonia Solution, Strong SCHEMBL29399251 | 0.99 | LTA4H (0.53) | LTA4HMEN1ALDH1A1LMNAKMT2A | |
| Ammonia Solution, Strong SCHEMBL9816149 | 0.99 | LTA4H (0.53) | LTA4HMEN1ALDH1A1LMNAKMT2A | |
| Ammonia Solution, Strong SCHEMBL29370733 | 0.99 | LTA4H (0.53) | LTA4HMEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL29193905 | 0.88 | LTA4H (0.43) | LTA4HMEN1KMT2AGRM8GRM4 | |
| SCHEMBL9816016 | 0.85 | LTA4H (0.53) | LTA4HMEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL8378243 | 0.83 | LTA4H (0.46) | LTA4HALDH1A1LMNA | |
| SCHEMBL31458519 | 0.83 | LTA4H (0.46) | LTA4HALDH1A1LMNA | |
| SCHEMBL11097431 | 0.83 | LTA4H (0.51) | LTA4HMEN1ALDH1A1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630027-A1 | COMPOSITE AIDS VACCINE GENERATING ANTI-HIV SPECIFIC NEUTRALIZING ANTIBODIES AND/OR ANTI-HIV CYTOTOXIC T CELLS | DYS-Immune Therapeutics (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2025179362-A1 | FISH VACCINE, USE THEREOF AND METHOD OF PREPARATION | FARMACORE BIOTECNOLOGIA LTDA (BR) | 2025-09-04 | — | — | WO | disclosed |
| CN-115436617-B | Dry-type analysis reagent for gamma-glutamyl transpeptidase detection | 乐凯医疗科技有限公司 | 2025-09-02 | — | — | CN | disclosed |
| CN-119306640-A | Gamma-glutamyl transpeptidase detection substrate and preparation method and application thereof | 英科新创(厦门)科技股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| EP-4441190-A1 | N-SUBSTITUTED 2-(6-HYDROXY-3-OXO-3H-XANTHENE-9-YL)BENZAMIDES AS PHOTOACTIVATORS IN DETERGENTS | Henkel AG & Co. KGaA (DE) | 2024-10-09 | — | — | EP | disclosed |
| US-20240199766-A1 | OXIDIZED POLYSACCHARIDE DERIVATIVES | Nutrition & Biosciences USA 4, Inc. | 2024-06-20 | — | — | US | disclosed |
| WO-2024121424-A1 | COMPOSITE AIDS VACCINE GENERATING ANTI-HIV SPECIFIC NEUTRALIZING ANTIBODIES AND/OR ANTI-HIV CYTOTOXIC T CELLS | ZAGURY DANIEL (FR) | 2024-06-13 | — | — | WO | disclosed |
| US-20240150497-A1 | POLYSACCHARIDE DERIVATIVES FOR DETERGENT COMPOSITIONS | Nutrition & Biosciences USA 4, Inc. | 2024-05-09 | — | — | US | disclosed |
| US-11957748-B2 | Vaccine to pathogenic immune activation cells during infections | 21 C Bio (FR) | 2024-04-16 | — | — | US | disclosed |
| CN-117413035-A | Adhesive composition and adhesive tape | 日东电工株式会社 | 2024-01-16 | — | — | CN | disclosed |
| CN-116284466-A | Polysaccharide monomer separated from schisandra chinensis, preparation method and application thereof | 梁军 | 2023-06-23 | — | — | CN | disclosed |
| WO-2023099294-A1 | N-SUBSTITUTED 2-(6-HYDROXY-3-OXO-3H-XANTHENE-9-YL)BENZAMIDES AS PHOTOACTIVATORS IN DETERGENTS | HENKEL AG & CO. KGAA (DE) | 2023-06-08 | — | — | WO | disclosed |
| CN-116134055-A | Poly alpha-1, 6-glucan derivative and composition comprising same | 营养与生物科学美国4公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-115836120-A | Treatment compositions comprising cationic poly alpha-1, 6-glucan ethers | 宝洁公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-4135538-A1 | ORAL CARE COMPOSITIONS AND METHODS | Per Os Biosciences, LLC (US) | 2023-02-22 | — | — | EP | disclosed |
| CN-115667479-A | Laundry care or dish care compositions comprising poly alpha-1, 6-glucan derivatives | 宝洁公司 | 2023-01-31 | — | — | CN | disclosed |
| WO-2022131893-A1 | NATIVE STARCHES OF FRUITS OF THE GENUS MANGIFERA AND METHOD OF EXTRACTION THEREOF | UNIVERSIDAD AUTÓNOMA DE NAYARIT (MX) | 2022-06-23 | — | — | WO | disclosed |
| EP-3707168-B1 | UNIQUE MORPHOLOGICAL POLYSACCHARIDE | NUTRITION & BIOSCIENCES USA 4 INC (US) | 2022-03-30 | — | — | EP | disclosed |
| CN-114025792-A | Vaccine against pathogenic immune-activated cells during infection | 21C生物公司 | 2022-02-08 | — | — | CN | disclosed |
| EP-3941517-A1 | VACCINE TO PATHOGENIC IMMUNE ACTIVATION CELLS DURING INFECTIONS | 21C BIO (FR) | 2022-01-26 | — | — | EP | disclosed |